Here’s the caveat – not all CBD products are created equal and, as we know, marketing guidelines can be somewhat lax, so it’s difficult to separate the wheat from the chaff. As a rough guide, experts say that for most adults, 10mg is fine to start and we needn’t worry about overdosing as scientists are confident that, even at excess, CBD use isn’t dangerous (just be sure to tell your doctor in case it interferes with existing medication). For added reassurance, the World Health Organisation states: ‘In humans, CBD exhibits no effects indicative of any abuse or dependence potential… To date, there is no evidence of public health related problems associated with the use of pure CBD.’ This goes for dosages up to 5000mg a day and to put this into context, some of the products commonly found on the UK market today start at just 1mg.
Cannabidiol is an active ingredient derived from the hemp plant, a cousin of the marijuana plant
But how much do you really know about CBD and what is the best way to benefit from it? We spoke to IVNT (intravenous nutrient therapy) specialist and founder of Vitamin Injections London, Bianca Estelle, to hear all about the launch of London’s first ever CBD injection and how this compares to its product predecessors.
What are the benefits?
CBD stands for cannabidiol and is an active ingredient derived from the hemp plant, a cousin of the marijuana (cannabis) plant. Unlike THC, which is also found in marijuana, CBD doesn’t cause intoxication or a high and is therefore safe for use. In fact, there has been evidence to show that it can treat the symptoms of epilepsy but in recent times, its more widely adopted for its general health and wellness benefits.
Since the birth of this wellness trend, circa 2018, CBD (cannabidiol) has featured in countless health, beauty and food products, but, like many consumer-led products, due diligence should be carried out before investment to ensure you’re benefiting from the real deal.
In a nutshell, CBD delivery via injection offers higher concentrations, compared to other alternatives. Company founder Bianca Estelle explains: “Having followed and acutely analysed the popularity of CBD over the last few years, I am thrilled to be able to apply my knowledge and experience to offer the first and only CBD injection here in London. Many clients will benefit from the properties of CBD in a highly concentrated, injectable format and the research and development that we have taken to launch this has been worth the wait.”
By far, the most popular way to take CBD is with an oil or tincture, applied under the tongue, but, if we look at the best way to ensure that active ingredients (including vitamins) reach the bloodstream, there may be a better way. Enter Vitamin Injections London and its new CBD injection. Based in London’s affluent Marylebone, the clinic specialises in offering vitamin nutrient therapy, to promote health and wellbeing from the inside out.
Although some controlled studies employed injectable forms of THC, these formulations were pharmaceutical-grade, and the injections were performed by licensed medical professionals. Over the years, there have been cases of people shooting up their own homemade weed broths, which can trigger a potentially lethal condition called “intravenously injected marijuana disorder.” The disorder causes bouts of vomiting, intense muscle pain, and heart issues.
Biota Biosciences is just the latest CBD company to incur the FDA’s wrath. Marijuana Moment noted that the federal agency has been issuing warnings to unscrupulous CBD producers practically non-stop since the US government legalized CBD — and its primary plant source, hemp — at the end of 2018. Other “outlandish” medical claims cited by the FDA include some CBD companies marketing their products as cures for cancer or COVID-19.
Federal law states that any product that claims to treat medical conditions is considered a drug. To legally market as a drug, the product must undergo stringent clinical trials that are approved by the FDA. Biota Biosciences did not subject its injectable CBD products to this process.
There’s a running joke in the online cannabis community that kids are falling prey to “bong injections,” where they shoot up weed smoke like heroin. But as the cannabis industry becomes saturated with the same ol’ products that only differ in packaging, competition has gotten fierce, prompting one startup to develop an unconventional intravenous CBD product that’s now been recalled due to allegedly violating federal regulations.
Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval https://t.co/hAYSW5IxDX pic.twitter.com/QxxoD8pCNI— U.S. FDA Recalls (@FDArecalls) May 21, 2020
On Friday, Biota Biosciences published a letter on its website announcing its Sterile Vial recall and the hazards that the company potentially introduced to a new, burgeoning CBD market. The letter noted that, “[U]napproved drugs intended to be administered directly into the bloodstream can pose a serious risk of harm to users because they bypass many of the body’s natural defenses against toxic ingredients, toxins, or dangerous organisms that can lead to serious and life-threatening conditions such as septicemia or sepsis,” two life-threatening bacterial infections.
On Thursday, the US FDA announced on Twitter that Biota Biosciences recalled its “Cannabidiol (CBD) Complex,” “Cannabidiol+Curcumin,” and “Curcumin Complex” products previously offered under the company’s Sterile Vial line. According to a cease-and-desist letter issued by the FDA in April, the company made unfounded medical claims on its products’ packaging, such as the products’ supposed efficacies for treating opioid addiction, auto-immune disorders, and chronic pain. The FDA also charged the company with failing to include instructions for safely injecting its CBD and herbal products.